The Effectiveness of Dry Needling on Spasticity

The Effectiveness of Dry Needling on Upper and Lower Dysfunction on stroke patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171111037388N4

Enrollment

Registered

2019-04-07

Start date

2018-06-01

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Stroke. Stroke, not specified as hemorrhage or infarction

Interventions

Intervention 1: Intervention group: A specialist who has expertise in dry needling, will deliver three sessions of dry needling on the spastic muscles of the upper and lower extremities on the hemiple

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: first brain stroke Sufficient communication skills to show yes / no verbally or through gestures be able to walk for at least 10 meter MMAS score equal or more than one unilateral hemiparesis

Exclusion criteria

Exclusion criteria: unable patients to follow the instructions severe musculoskeletal disorders (For example, severe osteoporosis, arthritis} psychiatric disorders requiring drug therapy cognitive disorders contraindication to dry needling using anti-spastic drugs

Design outcomes

Primary

Measure	Time frame
Walking speed. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: 10 meter walking test.;Spasticity. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: modified modified ashworth scale.;Mobility. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Timed up and go test.;Hand dexterity. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Box and Block test.	—

Measure

Time frame

Walking speed. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: 10 meter walking test.;Spasticity. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: modified modified ashworth scale.;Mobility. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Timed up and go test.;Hand dexterity. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Box and Block test.

—

Secondary

Measure	Time frame
Balance. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Single Leg Stance Test.;Daily living activity. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Barthel index.;Range of motion. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: goniometer.;Pennation angle of gastrocnemius muscle. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: sonography.;Gastrocnemius muscle thickness. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: sonography.	—

Measure

Time frame

Balance. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Single Leg Stance Test.;Daily living activity. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: Barthel index.;Range of motion. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: goniometer.;Pennation angle of gastrocnemius muscle. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: sonography.;Gastrocnemius muscle thickness. Timepoint: Baseline, immediately after treatment and after 4 weeks. Method of measurement: sonography.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArdalan Shariat

Tehran University of Medical Sciences

ardalansh2002@gmail.com+98 939 861 4772

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026